Skip to Main Content

Paper Details

Enhancing Anti-SARS-CoV-2 Neutralizing Immunity by Genetic Delivery of Enveloped Virus-like Particles Displaying SARS-CoV-2 Spikes.
Vaccines (Basel)
0
2023
Beta, Beta variant, COVID-19, Enveloped, Enveloped Virus-like Particles, NDVLPs, Newcastle disease virus, S, S-2P, S-2P-, S-2P-NDVLP-1T, S-2P-NDVLP-3T, SARS-CoV, SARS-CoV-2, SARS-CoV-2 Spikes, T-cell, WA, eVLP, eVLPs, mRNA, mice, multiple-gene transcript, murine, protein subunit-DNA construct, single-gene-transcript, single-gene-transcript DNA construct
Author NameAffiliation
Yongping YangVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Yaroslav TsybovskyVaccine Research Center Electron Microscopy Unit, Frederick National Laboratory for Cancer Research
Lingshu WangVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Baoshan ZhangVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Reda RawiVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
John R MascolaVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Peter D KwongVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
  • 1 - 7

Datasets

Release 1.2